JHS vs PGHH: Stock Comparison
JHS Svendgaard Laboratories Limited vs Procter & Gamble Hygiene and Health Care Limited
Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings
Procter & Gamble Hygiene and Health Care Limited is the larger company by market capitalisation. JHS Svendgaard Laboratories Limited shows faster revenue growth, while Procter & Gamble Hygiene and Health Care Limited shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Side-by-side comparison of JHS Svendgaard Laboratories Limited and Procter & Gamble Hygiene and Health Care Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | JHS | PGHH |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Fast Moving Consumer Goods |
| Industry | Personal Care | Personal Care |
Price
| Metric | JHS | PGHH |
|---|---|---|
| Live Price | ₹7.49 | ₹8,974.5 |
| Day Change | 2.46% | -0.11% |
| Volume | 18,572 | 15,433 |
| 52-Week High | ₹13.9 | ₹14,540 |
| 52-Week Low | ₹6.26 | ₹8,680 |
| Distance from 52W High | -46.12% | -38.28% |
Valuation
| Metric | JHS | PGHH |
|---|---|---|
| Market Cap | ₹64 Cr | ₹29,075 Cr |
| P/E Ratio | — | 34.07x |
| P/B Ratio | — | 38.73x |
| EPS | ₹-0.22 | ₹263.43 |
| Book Value | ₹19.98 | ₹232.1 |
| Dividend Yield | 0% | 2.64% |
Growth
| Metric | JHS | PGHH |
|---|---|---|
| Revenue Growth (TTM YoY) | 39.2% | -5.1% |
| EPS Growth (TTM YoY) | 0% | -1.9% |
| Qtr Sales Growth | 29.9% | -5.07% |
| Qtr Profit Growth | 12.9% | -1.9% |
Profitability & Leverage
| Metric | JHS | PGHH |
|---|---|---|
| ROE | -1.11% | 115% |
| ROCE | -0.78% | 157% |
| Net Margin | -1.89% | 20% |
| Operating Margin | 2.58% | 27.3% |
| Debt to Equity | 0.09x | 0x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | JHS | PGHH |
|---|---|---|
| Promoter Holding | 33.85% | 1.91% |
| FII Holding | 3.14%▼ 0.46 pp | 0.98%▲ 0.01 pp |
| DII Holding | 0% | 15.59%▼ 0.38 pp |
| Public Holding | 63.01%▲ 0.45 pp | 12.8%▲ 0.37 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: JHS Svendgaard Laboratories Limited and Procter & Gamble Hygiene and Health Care Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.